The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened
Open accessAbstract
The Hedgehog-GLI (HH-GLI) pathway is a highly conserved signaling that plays a critical role in controlling cell specification, cell-cell interaction and tissue patterning during embryonic development. Canonical activation of HH-GLI signaling occurs through binding of HH ligands to the twelve-pass transmembrane receptor Patched 1 (PTCH1), which derepresses the seven-pass transmembrane G protein-coupled receptor Smoothened (SMO). Thus, active SMO initiates a complex intracellular cascade that leads to the activation of the three GLI transcription factors, the final effectors of the HH-GLI pathway. Aberrant activation of this signaling has been implicated in a wide variety of tumors, such as those of the brain, skin, breast, gastrointestinal, lung, pancreas, prostate and ovary. In several of these cases, activation of HH-GLI signaling is mediated by overproduction of HH ligands (e.g. prostate cancer), loss-of-function mutations in PTCH1 or gain-of-function mutations in SMO, which occur in the majority of basal cell carcinoma (BCC), SHH-subtype medulloblastoma and rhabdomyosarcoma. Besides the classical canonical ligand-PTCH1-SMO route, mounting evidence points toward additional, non canonical ways of GLI activation in cancer. By non canonical we refer to all those mechanisms of activation of the GLI transcription factors occurring independently of SMO. Often, in a give cancer type canonical and non canonical activation of HH-GLI signaling co-exist, and in some cancer types, more than one mechanism of non canonical activation may occur. Tumors harboring non canonical HH-GLI signaling are less sensitive to SMO inhibition, posing a threat for therapeutic efficacy of these antagonists. Here we will review the most recent findings on the involvement of alternative signaling pathways in inducing GLI activity in cancer and stem cells. We will also discuss the rationale of targeting these oncogenic pathways in combination with HH-GLI inhibitors as a promising anti-cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation of chromatin by histone modifications
Bannister, A. J., & Kouzarides, T. (2011) · Cell Research · doi:10.1038/cr.2011.22 · Cited by 6,012
Hedgehog signaling in animal development: paradigms and principles
Ingham, P. W., & McMahon, A. P. (2001) · Genes & Development · doi:10.1101/gad.938601 · Cited by 2,985
Drug delivery with carbon nanotubes for in vivo cancer treatment
Liu, Z., Chen, K., Davis, C. R., Sherlock, S. P., Cao, Q., Chen, X. S., & Dai, H. (2008) · PubMed · doi:10.48550/arxiv.0808.2070 · Cited by 2,286
The primary cilium: a signalling centre during vertebrate development
Goetz, S. C., & Anderson, K. V. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2774 · Cited by 1,824
Vertebrate Smoothened functions at the primary cilium
Corbit, K. C., Aanstad, P., Singla, V., Norman, A. R., Stainier, D. Y. R., & Reiter, J. F. (2005) · Nature · doi:10.1038/nature04117 · Cited by 1,481
MicroRNAs and other non-coding RNAs as targets for anticancer drug development
Ling, H., Fabbri, M., & Calin, G. A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4140 · Cited by 1,465
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma
Sekulic, A., Migden, M. R., Oro, A. E., Dirix, L., Lewis, K. D., Hainsworth, J. D., Solomon, J. A., Yoo, S., Arron, S. T., Friedlander, P. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113713 · Cited by 1,464
Patched1 Regulates Hedgehog Signaling at the Primary Cilium
Rohatgi, R., Milenkovic, L., & Scott, M. P. (2007) · Science · doi:10.1126/science.1139740 · Cited by 1,426
Unravelling mechanisms of p53-mediated tumour suppression
Bieging, K. T., Mello, S. S., & Attardi, L. D. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3711 · Cited by 1,387
Hedgehog: functions and mechanisms
Varjosalo, M., & Taipale, J. (2008) · Genes & Development · doi:10.1101/gad.1693608 · Cited by 1,217
Targeting RAS–ERK signalling in cancer: promises and challenges
Samatar, A. A., & Poulikakos, P. I. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4281 · Cited by 1,163
Yu, J. S. L., & Cui, W. (2016) · Development · doi:10.1242/dev.137075 · Cited by 1,135
Protein arginine methyltransferases and cancer
Yang, Y., & Bedford, M. T. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3409 · Cited by 1,083
Targeting the Hedgehog pathway in cancer
Rubin, L. L., & de Sauvage, F. J. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2086 · Cited by 949
Contextual determinants of TGFβ action in development, immunity and cancer
David, C. J., & Massagué, J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0007-0 · Cited by 851 · cited 1×
“During carcinogenesis, TGFβ signaling can act both as tumor suppressor or oncogene depending on tumor type and stage (David and Massagué, 2018).”
BackgroundWong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., & Vogelstein, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.19.6899 · Cited by 849
Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists
Lauth, M., Bergström, Å., Shimokawa, T., & Toftgård, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609699104 · Cited by 782
EGFR-TKI resistance due to BIM polymorphism can be circumvented in combination with HDAC inhibition
中川, 学. (2014) · Institutional Repositories DataBase (IRDB) · Cited by 736
Crystal Structure of a Five-Finger GLI-DNA Complex: New Perspectives on Zinc Fingers
Pavletich, N. P., & Pabo, C. O. (1993) · Science · doi:10.1126/science.8378770 · Cited by 669
Sonic hedgehog controls stem cell behavior in the postnatal and adult brain
Palma, V., Lim, D. A., Dahmane, N., Sánchez, P., Brionne, T. C., Herzberg, C. D., Gitton, Y., Carleton, A., Álvarez-Buylla, A., & Altaba, A. R. I. (2005) · Development · doi:10.1242/dev.01567 · Cited by 611
Buonamici, S., Williams, J., Morrissey, M., Wang, A., Guo, R., Vattay, A., Hsiao, K., Yuan, J., Green, J., Ospina, B., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001599 · Cited by 562
Unraveling the therapeutic potential of the Hedgehog pathway in cancer
Amakye, D., Jagani, Z., & Dorsch, M. (2013) · Nature Medicine · doi:10.1038/nm.3389 · Cited by 547
LoRusso, P. M., Rudin, C. M., Reddy, J. C., Tibes, R., Weiss, G. J., Borad, M. J., Hann, C. L., Brahmer, J. R., Chang, I., Darbonne, W. C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2745 · Cited by 544
Hedgehog Induces Opposite Changes in Turnover and Subcellular Localization of Patched and Smoothened
Denef, N., Neubüser, D., Perez, L., & Cohen, S. M. (2000) · Cell · doi:10.1016/s0092-8674(00)00056-8 · Cited by 531
Stecca, B., Mas, C., Clement, V., Zbinden, M., Correa, R., Piguet, V., Beermann, F., & Ruiz i Altaba, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700776104 · Cited by 530
Self-citationKatoh, Y., & Katoh, M. (2009) · Current Molecular Medicine · doi:10.2174/156652409789105570 · Cited by 525
Pan, Y., Bai, C. B., Joyner, A. L., & Wang, B. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.9.3365-3377.2006 · Cited by 518
Mammalian Suppressor-of-Fused modulates nuclear–cytoplasmic shuttling of GLI-1
Kogerman, P., Grimm, T., Kogerman, L., Krause, D., Undén, A. B., Sandstedt, B., Toftgård, R., & Zaphiropoulos, P. G. (1999) · Nature Cell Biology · doi:10.1038/13031 · Cited by 476
The GLI gene encodes a nuclear protein which binds specific sequences in the human genome.
Kinzler, K. W., & Vogelstein, B. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.2.634 · Cited by 475
Sonic Hedgehog-induced Activation of the Gli1Promoter Is Mediated by GLI3
Dai, P., Akimaru, H., Tanaka, Y., Maekawa, T., Nakafuku, M., & Ishii, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.8143 · Cited by 466
Phosphoinositide 3-kinase and Akt are essential for Sonic Hedgehog signaling
Riobó, N. A., Lu, K., Ai, X., Haines, G. M., & Emerson, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504337103 · Cited by 439
Role of microRNAs in translation regulation and cancer
Oliveto, S., Mancino, M., Manfrini, N., & Biffo, S. (2017) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v8.i1.45 · Cited by 431
Hedgehog beyond medulloblastoma and basal cell carcinoma
Teglund, S., & Toftgård, R. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.01.003 · Cited by 426
Structure and acetyl-lysine recognition of the bromodomain
Mujtaba, S., Zeng, L., & Zhou, M.-M. (2007) · Oncogene · doi:10.1038/sj.onc.1210618 · Cited by 421
Smoothened Variants Explain the Majority of Drug Resistance in Basal Cell Carcinoma
Atwood, S. X., Sarin, K. Y., Whitson, R. J., Li, J. R., Kim, G., Rezaee, M., Ally, M. S., Kim, J., Yao, C., Chang, A. L. S., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.002 · Cited by 404
Nolan-Stevaux, O., Lau, J., Truitt, M. L., Chu, G. C., Hebrok, M., Fernández-Zapico, M. E., & Hanahan, D. (2009) · Genes & Development · doi:10.1101/gad.1753809 · Cited by 383
Genomic Analysis of Smoothened Inhibitor Resistance in Basal Cell Carcinoma
Sharpe, H. J., Pau, G., Dijkgraaf, G. J., Basset-Seguin, N., Modrusan, Z., Januario, T., Tsui, V., Durham, A. B., Dlugosz, A. A., Haverty, P. M., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.001 · Cited by 382
Dijkgraaf, G. J. P., Alicke, B., Weinmann, L., Januario, T., West, K., Modrusan, Z., Burdick, D., Goldsmith, R., Robarge, K., Sutherlin, D., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2876 · Cited by 363
Stem Cell Pathways Contribute to Clinical Chemoresistance in Ovarian Cancer
Steg, A. D., Bevis, K. S., Katre, A. A., Ziebarth, A., Dobbin, Z. C., Alvarez, R. D., Zhang, K., Conner, M., & Landen, C. N. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2188 · Cited by 359
Beauchamp, E. M., Ringer, L., Bulut, G., Sajwan, K. P., Hall, M. D., Lee, Y.-C., Peaceman, D., Özdemirli, M., Rodriguez, O., Macdonald, T. J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci42874 · Cited by 351
The Crosstalk of mTOR/S6K1 and Hedgehog Pathways
Wang, Y., Ding, Q., Yen, C.-J., Xia, W., Izzo, J. G., Lang, J.-Y., Li, C.-W., Hsu, J. L., Miller, S. A., Wang, X., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2011.12.028 · Cited by 346
Dennler, S., André, J., Alexaki, I., Li, A., Magnaldo, T., ten Dijke, P., Wang, X.-J., Verrecchia, F., & Mauviel, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0491 · Cited by 342
Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells
Ferretti, E., De Smaele, E., Miele, E., Laneve, P., Po, A., Pelloni, M., Paganelli, A., Di Marcotullio, L., Caffarelli, E., Screpanti, I., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.172 · Cited by 332
Canettieri, G., Di Marcotullio, L., Greco, A., Coni, S., Antonucci, L., Infante, P., Pietrosanti, L., De Smaele, E., Ferretti, E., Miele, E., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2013 · Cited by 322
Epigenetic targeting of Hedgehog pathway transcriptional output through BET bromodomain inhibition
Tang, Y., Gholamin, S., Schubert, S., Willardson, M. I., Lee, A., Bandopadhayay, P., Bergthold, G., Masoud, S., Nguyen, B., Vue, N., et al. (2014) · Nature Medicine · doi:10.1038/nm.3613 · Cited by 314
Hedgehog/Ras interactions regulate early stages of pancreatic cancer
Pasca di Magliano, M., Sekine, S., Ermilov, A., Ferris, J., Dlugosz, A. A., & Hebrok, M. (2006) · Genes & Development · doi:10.1101/gad.1470806 · Cited by 307
Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade
Hyman, J. M., Firestone, A. J., Heine, V. M., Zhao, Y., Ocasio, C. A., Han, K., Sun, M., Rack, P. G., Sinha, S., Wu, J. J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907134106 · Cited by 305
Kim, J., Lee, J. J., Kim, J., Gardner, D., & Beachy, P. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006822107 · Cited by 304
Oncogenic KRAS Activates Hedgehog Signaling Pathway in Pancreatic Cancer Cells
Ji, Z., Mei, F. C., Xie, J., & Cheng, X. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611089200 · Cited by 296
Justilien, V., Walsh, M. P., Ali, S. A., Thompson, E. A., Murray, N. R., & Fields, A. P. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.01.008 · Cited by 293
Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat
Teperino, R., Amann, S., Bayer, M., McGee, S. L., Loipetzberger, A., Connor, T., Jaeger, C., Kammerer, B., Winter, L., Wiche, G., et al. (2012) · Cell · doi:10.1016/j.cell.2012.09.021 · Cited by 283
Tang, Y.-A., Chen, Y.-F., Bao, Y., Mahara, S., Yatim, S. M. J. M., Oguz, G., Lee, P. L., Feng, M., Cai, Y., Tan, E. Y., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801348115 · Cited by 277
Numb is a suppressor of Hedgehog signalling and targets Gli1 for Itch-dependent ubiquitination
Marcotullio, L. D., Ferretti, E., Greco, A., De Smaele, E., Po, A., Sico, M. A., Alimandi, M., Giannini, G., Maroder, M., Screpanti, I., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1510 · Cited by 275
Palma, V., & Altaba, A. R. I. (2004) · Development · doi:10.1242/dev.00930 · Cited by 274
β-Arrestin–Mediated Localization of Smoothened to the Primary Cilium
Kovacs, J. J., Whalen, E. J., Liu, R., Xiao, K., Kim, J., Chen, M., Wang, J., Chen, W., & Lefkowitz, R. J. (2008) · Science · doi:10.1126/science.1157983 · Cited by 274
Evidence for the direct involvement of βTrCP in Gli3 protein processing
Wang, B., & Li, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509927103 · Cited by 273
Hedgehog Signaling in the Maintenance of Cancer Stem Cells
Cochrane, C., Szczepny, A., Watkins, D., & Cain, J. (2015) · Cancers · doi:10.3390/cancers7030851 · Cited by 271
Review: Targeting the Hedgehog pathway in cancer
Gupta, S., Takebe, N., & LoRusso, P. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010366430 · Cited by 259
Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway
Jagani, Z., Mora-Blanco, E. L., Sansam, C. G., McKenna, E. S., Wilson, B., Chen, D., Klekota, J., Tamayo, P., Nguyen, P. T. L., Tolstorukov, M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2251 · Cited by 251
Regl, G., Kasper, M., Schnidar, H., Eichberger, T., Neill, G. W., Philpott, M. P., Esterbauer, H., Hauser-Kronberger, C., Frischauf, A.-M., & Aberger, F. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1085 · Cited by 248
Gli Protein Activity Is Controlled by Multisite Phosphorylation in Vertebrate Hedgehog Signaling
Niewiadomski, P., Kong, J. H., Ahrends, R., Ma, Y., Humke, E. W., Khan, S., Teruel, M. N., Novitch, B. G., & Rohatgi, R. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.003 · Cited by 239
GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas
Atwood, S. X., Li, M., Lee, A., Tang, J. Y., & Oro, A. E. (2013) · Nature · doi:10.1038/nature11889 · Cited by 237
A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
Stecca, B., & Ruiz i Altaba, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.16 · Cited by 233
Self-citationRodon, J., Tawbi, H. A., Thomas, A. L., Stoller, R. G., Turtschi, C. P., Baselga, J., Sarantopoulos, J., Mahalingam, D., Shou, Y., Moles, M. A., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1710 · Cited by 231
Chen, Y., Sasai, N., Ma, G., Yue, T., Jia, J., Briscoe, J., & Jiang, J. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001083 · Cited by 225 · cited 2×
“For treatment involving SMO inhibitors (alone or in combination with other pathway inhibitors), a better biomarker for SMO activation should be developed, such as phospho-specific antibody to monitor SMO phosphorylation (Chen et al., 2011).”
BackgroundSonic hedgehog acts at multiple stages during pancreatic tumorigenesis
Morton, J. P., Mongeau, M. E., Klimstra, D. S., Morris, J. P., Lee, Y. C., Kawaguchi, Y., Wright, C. V. E., Hebrok, M., & Lewis, B. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701158104 · Cited by 223
Kasper, M., Schnidar, H., Neill, G. W., Hanneder, M., Klingler, S., Blaas, L., Schmid, C., Hauser-Kronberger, C., Regl, G., Philpott, M. P., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02317-05 · Cited by 220
Schnidar, H., Eberl, M., Klingler, S., Mangelberger, D., Kasper, M., Hauser-Kronberger, C., Regl, G., Kroismayr, R., Moriggl, R., Sibilia, M., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2331 · Cited by 212
Learning from Jekyll to control Hyde: Hedgehog signaling in development and cancer
Barakat, M. T., Humke, E. W., & Scott, M. P. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.05.003 · Cited by 211
Hedgehog signaling: modulation of cancer properies and tumor mircroenvironment
Hanna, A., & Shevde, L. A. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0509-3 · Cited by 205
Johnson, R. W., Nguyen, M. P., Padalecki, S. S., Grubbs, B. G., Merkel, A. R., Oyajobi, B. O., Matrisian, L. M., Mundy, G. R., & Sterling, J. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2993 · Cited by 197
The multiple functions of Numb
Gulino, A., Di Marcotullio, L., & Screpanti, I. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.11.017 · Cited by 192
Regulation of Gli1 Transcriptional Activity in the Nucleus by Dyrk1
Mao, J., Maye, P., Kogerman, P., Tejedor, F. J., Toftgard, R., Xie, W., Wu, G., & Wu, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206743200 · Cited by 190
Dual degradation signals control Gli protein stability and tumor formation
Huntzicker, E. G., Estay, I. S., Zhen, H., Lokteva, L. A., Jackson, P. K., & Oro, A. E. (2006) · Genes & Development · doi:10.1101/gad.1380906 · Cited by 187
Grachtchouk, M., Pero, J., Yang, S. H., Ermilov, A. N., Michael, L. E., Wang, A., Wilbert, D., Patel, R. M., Ferris, J., Diener, J., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46307 · Cited by 184
Varjosalo, M., Björklund, M., Cheng, F., Syvänen, H., Kivioja, T., Kilpinen, S., Sun, Z., Kallioniemi, O., Stunnenberg, H. G., He, W.-W., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.047 · Cited by 183
Riobo, N. A., Haines, G. M., & Emerson, C. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2539 · Cited by 181
Roessler, E., Ermilov, A. N., Grange, D. K., Wang, A., Grachtchouk, M., Dlugosz, A. A., & Muenke, M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi222 · Cited by 174
Ikram, M. S., Neill, G. W., Regl, G., Eichberger, T., Frischauf, A.-M., Aberger, F., Quinn, A., & Philpott, M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22612.x · Cited by 171
GLI1 Is a Direct Transcriptional Target of EWS-FLI1 Oncoprotein
Beauchamp, E., Bulut, G., Abaan, O., Chen, K., Merchant, A., Matsui, W., Endo, Y., Rubin, J. S., Toretsky, J., & Üren, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806233200 · Cited by 170
Peterson, K. A., Nishi, Y., Ma, W., Vedenko, A., Shokri, L., Zhang, X., McFarlane, M., Baizabal, J.-M., Junker, J. P., van Oudenaarden, A., et al. (2012) · Genes & Development · doi:10.1101/gad.207142.112 · Cited by 170
GLI2-Mediated Melanoma Invasion and Metastasis
Alexaki, V.-I., Javelaud, D., Van Kempen, L. C. L., Mohammad, K. S., Dennler, S., Luciani, F., Hoek, K. S., Juàrez, P., Goydos, J. S., Fournier, P. J., et al. (2010) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djq257 · Cited by 168
Brechbiel, J., Miller-Moslin, K., & Adjei, A. A. (2014) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2014.02.003 · Cited by 167
Eberl, M., Klingler, S., Mangelberger, D., Loipetzberger, A., Damhofer, H., Zoidl, K., Schnidar, H., Hache, H., Bauer, H., Solca, F., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100201 · Cited by 165
Dummer, R., Guminski, A., Gutzmer, R., Dirix, L., Lewis, K. D., Combemale, P., Herd, R. M., Kaatz, M., Loquai, C., Stratigos, A. J., et al. (2016) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2016.02.1226 · Cited by 164
Sharma, N., Nanta, R., Sharma, J. P., Gunewardena, S., Singh, K. P., Shankar, S., & Srivastava, R. K. (2015) · Oncotarget · doi:10.18632/oncotarget.5055 · Cited by 163
DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS
Lauth, M., Bergström, Å., Shimokawa, T., Tostar, U., Jin, Q., Fendrich, V., Guerra, C. E., Barbacid, M., & Toftgård, R. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1833 · Cited by 163
Gli1/ DNA interaction is a druggable target for Hedgehog‐dependent tumors
Infante, P., Mori, M., Alfonsi, R., Ghirga, F., Aiello, F., Toscano, S., Ingallina, C., Siler, M., Cucchi, D., Po, A., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201489213 · Cited by 163
Filbin, M. G., Dabral, S. K., Pazyra‐Murphy, M. F., Ramkissoon, S. H., Kung, A. L., Pak, E., Chung, J. Y., Theisen, M., Sun, Y., Franchetti, Y., et al. (2013) · Nature Medicine · doi:10.1038/nm.3328 · Cited by 162
Zhao, X., Ponomaryov, T., Ornell, K. J., Zhou, P., Dabral, S. K., Pak, E., Li, W., Atwood, S. X., Whitson, R. J., Chang, A. L. S., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2999-t · Cited by 160
Mechanisms Regulating Protein Localization
Bauer, N. C., Doetsch, P. W., & Corbett, A. H. (2015) · Traffic · doi:10.1111/tra.12310 · Cited by 159
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
Pricl, S., Cortelazzi, B., Col, V. D., Marson, D., Laurini, E., Fermeglia, M., Licitra, L. F., Pilotti, S., Bossi, P., & Perrone, F. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.09.003 · Cited by 155
Cloning of the Human GLI2 Promoter
Dennler, S., André, J., Verrecchia, F., & Mauviel, A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.059964 · Cited by 153
A Novel Splice Variant of GLI1 That Promotes Glioblastoma Cell Migration and Invasion
Lo, H., Zhu, H., Cao, X., Aldrich, A. J., & Ali‐Osman, F. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0886 · Cited by 153
Pan, Y., & Wang, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m608599200 · Cited by 152
FOXC1 Activates Smoothened-Independent Hedgehog Signaling in Basal-like Breast Cancer
Han, B., Qu, Y., Jin, Y., Yu, Y., Deng, N., Wawrowsky, K., Zhang, X., Li, N., Bose, S., Wang, Q., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.063 · Cited by 150
Ahmad, A., Maitah, M. Y., Ginnebaugh, K. R., Li, Y., Bao, B., Gadgeel, S. M., & Sarkar, F. H. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-77 · Cited by 146
Cao, X., Geradts, J., Dewhirst, M. W., & Lo, H. (2011) · Oncogene · doi:10.1038/onc.2011.219 · Cited by 139
The EWS/FLI1 oncogenic transcription factor deregulates GLI1
Zwerner, J. P., Joo, J., Warner, K., Christensen, L., Hu‐Lieskovan, S., Triche, T. J., & May, W. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210991 · Cited by 135
Seto, M., Ohta, M., Asaoka, Y., Ikenoue, T., Tada, M., Miyabayashi, K., Mohri, D., Tanaka, Y., Ijichi, H., Tateishi, K., et al. (2009) · Molecular Carcinogenesis · doi:10.1002/mc.20516 · Cited by 127
Numb activates the E3 ligase Itch to control Gli1 function through a novel degradation signal
Marcotullio, L. D., Greco, A., Mazzà, D., Canettieri, G., Pietrosanti, L., Infante, P., Coni, S., Moretti, M., Smaele, E. D., Ferretti, E., et al. (2010) · Oncogene · doi:10.1038/onc.2010.394 · Cited by 124
Hedgehog pathway and GLI1 isoforms in human cancer.
Carpenter, R. L., & Lo, H. (2012) · PubMed · Cited by 121
Malatesta, M., Steinhauer, C., Mohammad, F., Pandey, D. P., Squatrito, M., & Helin, K. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4660 · Cited by 119
Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
Pò, A., Silvano, M., Miele, E., Capalbo, C., Eramo, A., Salvati, V., Todaro, M., Besharat, Z. M., Catanzaro, G., Cucchi, D., et al. (2017) · Oncogene · doi:10.1038/onc.2017.91 · Cited by 118
Yedjou, C. G., & Tchounwou, P. B. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9403-4 · Cited by 116
Long, J., Li, B., Rodríguez‐Blanco, J., Pastori, C., Volmar, C., Wahlestedt, C., Capobianco, A. J., Bai, F., Pei, X., Ayad, N. G., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.595348 · Cited by 112
Savona, M. R., Pollyea, D. A., Stock, W., Oehler, V. G., Schroeder, M. A., Lancet, J. E., McCloskey, J. K., Kantarjian, H. M., Ma, W. W., Shaik, M. N., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2824 · Cited by 108
Zhou, J., Zhu, G., Huang, J. X., Li, L., Du, Y., Gao, Y., Wu, D., Wang, X., Hsieh, J., He, D., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.006 · Cited by 107
Whitson, R. J., Lee, A. G., Urman, N. M., Mirza, A., Yao, C., Brown, A. S., Li, J., Shankar, G., Fry, M. A., Atwood, S. X., et al. (2018) · Nature Medicine · doi:10.1038/nm.4476 · Cited by 107
Sonic Hedgehog Signaling Pathway Is Activated in ALK-Positive Anaplastic Large Cell Lymphoma
Singh, R. R., Cho‐Vega, J. H., Davuluri, Y., Ma, S., Kasbidi, F., Milito, C. B., Lennon, P. A., Drakos, E., Medeiros, L. J., Luthra, R., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1808 · Cited by 104
Li, Y.-H., Luo, J., Mosley, Y. C., Hedrick, V., Paul, L. N., Chang, J., Zhang, G., Wang, Y., Banko, M. R., Brunet, A., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.054 · Cited by 101
Mazzà, D., Infante, P., Colicchia, V., Greco, A., Alfonsi, R., Siler, M., Antonucci, L., Pò, A., Smaele, E. D., Ferretti, E., et al. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.120 · Cited by 97
Whisenant, T. C., Ho, D. T., Benz, R. W., Rogers, J. S., Kaake, R. M., Gordon, E. A., Huang, L., Baldi, P., & Bardwell, L. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000908 · Cited by 97
The GLI genes as the molecular switch in disrupting Hedgehog signaling in colon cancer
Mazumdar, T., DeVecchio, J., Agyeman, A., Shi, T., & Houghton, J. A. (2011) · Oncotarget · doi:10.18632/oncotarget.310 · Cited by 97
Mimeault, M., Johansson, S. L., Venkatraman, G., Moore, E., Hénichart, J., Depreux, P., Lin, M., & Batra, S. K. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0648 · Cited by 91
Shimokawa, T., Tostar, U., Lauth, M., Palaniswamy, R., Kasper, M., Toftgård, R., & Zaphiropoulos, P. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800299200 · Cited by 87
Yamamoto, K., Tateishi, K., Kudo, Y., Hoshikawa, M., Tanaka, M. H., Nakatsuka, T., Fujiwara, H., Miyabayashi, K., Takahashi, R., Tanaka, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11129 · Cited by 86
D'Amico, D. F., Antonucci, L., Magno, L. D., Coni, S., Sdruscia, G., Macone, A., Miele, E., Infante, P., Marcotullio, L. D., Smaele, E. D., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.09.008 · Cited by 84
Götschel, F., Berg, D., Gruber, W., Bender, C., Eberl, M., Friedel, M., Sonntag, J., Rüngeler, E., Hache, H., Wierling, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065403 · Cited by 83
Ski is involved in transcriptional regulation by the repressor and full-length forms of Gli3Preprint
Dai, P., Shinagawa, T., Nomura, T., Harada, J., Kaul, S. C., Wadhwa, R., Khan, M. M., Akimaru, H., Sasaki, H., Colmenares, C., et al. (2002) · Genes & Development · doi:10.1101/gad.1017302 · Cited by 83
Miyazaki, Y., Matsubara, S., Ding, Q., Tsukasa, K., Yoshimitsu, M., Kosai, K.-I., & Takao, S. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0534-2 · Cited by 82
Rovida, E., & Stecca, B. A. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.08.003 · Cited by 81
Self-citationGLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors
Joo, J., Christensen, L., Warner, K., States, L. J., Kang, H.-G., Vo, K. T., Lawlor, E. R., & May, W. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007608 · Cited by 78
Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance
Palle, K., Mani, C., Tripathi, K. K., & Athar, M. (2015) · Cancers · doi:10.3390/cancers7040894 · Cited by 77
Coni, S., Mancuso, A. B., Di Magno, L., Sdruscia, G., Manni, S., Serrao, S. M., Rotili, D., Spiombi, E., Bufalieri, F., Petroni, M., et al. (2017) · Scientific Reports · doi:10.1038/srep44079 · Cited by 75
Singh, R. K., Dhanyamraju, P. K., & Lauth, M. (2016) · Oncotarget · doi:10.18632/oncotarget.13662 · Cited by 75
Non-consensus GLI binding sites in Hedgehog target gene regulation
Winklmayr, M., Schmid, C., Laner‐Plamberger, S., Kaser-Eichberger, A., Aberger, F., Eichberger, T., & Frischauf, A. (2010) · BMC Molecular Biology · doi:10.1186/1471-2199-11-2 · Cited by 73
Han, Y., Shi, Q., & Jiang, J. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421628112 · Cited by 71
Coni, S., Antonucci, L., D'Amico, D. F., Magno, L. D., Infante, P., Smaele, E. D., Giannini, G., Marcotullio, L. D., Screpanti, I., Gulino, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065718 · Cited by 71
Gioeli, D. G., Wunderlich, W., Sebolt, J. S., Bekiranov, S., Wulfkuhle, J. D., Petricoin, E. F., Conaway, M. C., & Weber, M. J. (2011) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-10-1033 · Cited by 71
Schneider, P., Bayo, J., Singh, R. K., Dhanyamraju, P. K., Holz, P. S., Baier, A., Fendrich, V., Ramaswamy, A., Baumeister, S., Martínez, E. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9023 · Cited by 69
Gruber, W., Hutzinger, M., Elmer, D. P., Parigger, T., Sternberg, C., Cegielkowski, L., Zaja, M., Leban, J. J., Michel, S., Hamm, S., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.6910 · Cited by 67
A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors
Wagner, A. J., Messersmith, W. A., Shaik, M. N., Li, S., Zheng, X., McLachlan, K. R., Cesari, R., Courtney, R., Levin, W. J., & El-Khoueiry, A. B. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1116 · Cited by 66
Hoch, L., Faure, H., Roudaut, H., Schoenfelder, A., Mann, A., Girard, N., Bihannic, L., Ayrault, O., Petricci, E., Taddei, M., et al. (2015) · The FASEB Journal · doi:10.1096/fj.14-267849 · Cited by 65
Neill, G. W., Ghali, L. R., Green, J. L., Ikram, M. S., Philpott, M. P., & Quinn, A. (2003) · PubMed · Cited by 65
Pietanza, M. C., Litvak, A. M., Varghese, A. M., Krug, L. M., Fleisher, M., Teitcher, J. B., Holodny, A. I., Sima, C. S., Woo, K. M., Ng, K., et al. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.04.014 · Cited by 65
Wang, Y., Hsu, J.-M., Kang, Y., Wei, Y., Lee, P., Chang, S.-J., Hsu, Y.-H., Hsu, J. L., Wang, H.-L., Chang, W., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0715 · Cited by 65
Miele, E., Pò, A., Begalli, F., Antonucci, L., Mastronuzzi, A., Marras, C. E., Carai, A., Cucchi, D., Abballe, L., Besharat, Z. M., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3477-0 · Cited by 65
Nye, M. D., Almada, L. L., Fernández‐Barrena, M. G., Marks, D. L., Elsawa, S. F., Vrabel, A. M., Tolosa, E. J., Ellenrieder, V., & Fernández-Zapico, M. E. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.545194 · Cited by 61
Canonical and Noncanonical Hedgehog/GLI Signaling in Hematological Malignancies
Aberger, F., Kern, D., Greil, R., & Hartmann, T. N. (2012) · Vitamins and hormones · doi:10.1016/b978-0-12-394622-5.00002-x · Cited by 60
Eimer, S., Dugay, F., Airiau, K., Avril, T., Quillien, V., Belaud‐Rotureau, M., & Belloc, F. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos266 · Cited by 60
Requirement of TGFβ Signaling for SMO-mediated Carcinogenesis
Fan, Q., He, M., Sheng, T., Zhang, X., Sinha, M., Luxon, B. A., Zhao, X., & Xie, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.164442 · Cited by 59
Zhao, D., & Cui, Z. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.7062 · Cited by 57
Role of Protein Kinases in Hedgehog Pathway Control and Implications for Cancer Therapy
Montagnani, V., & Stecca, B. A. (2019) · Cancers · doi:10.3390/cancers11040449 · Cited by 57
Self-citationHuang, Y., Nahar, S., Nakagawa, A., Fernández‐Barrena, M. G., Mertz, J. A., Bryant, B. M., Adams, C. E., Mino-Kenudson, M. A., Alt, K. N. V., Chang, K. K., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2068 · Cited by 56
Mirza, A., Fry, M. A., Urman, N. M., Atwood, S. X., Roffey, J., Ott, G. R., Chen, B., Lee, A. G., Brown, A. S., Aasi, S. Z., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.97071 · Cited by 56
Role and inhibition of GLI1 protein in cancer
Mastrangelo, E., & Milani, M. (2018) · Lung Cancer Targets and Therapy · doi:10.2147/lctt.s124483 · Cited by 56
Deng, W., Vanderbilt, D. B., Lin, C., Martin, K. H., Brundage, K. M., & Ruppert, J. M. (2015) · Journal of Cell Science · doi:10.1242/jcs.162164 · Cited by 55
Histone Deacetylase 6 Represents a Novel Drug Target in the Oncogenic Hedgehog Signaling Pathway
Dhanyamraju, P. K., Holz, P. S., Finkernagel, F., Fendrich, V., & Lauth, M. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0481 · Cited by 55
GLI2 Transcription Factor Mediates Cytokine Cross-talk in the Tumor Microenvironment
Elsawa, S. F., Almada, L. L., Ziesmer, S. C., Novak, A. J., Witzig, T. E., Ansell, S. M., & Fernández-Zapico, M. E. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.234146 · Cited by 54
Noncanonical Regulation of the Hedgehog Mediator GLI1 by c-MYC in Burkitt Lymphoma
Yoon, J. W., Gallant, M. L., Lamm, M. L. G., Iannaccone, S., Vieux, K.-F., Proytcheva, M. A., Hyjek, E. M., Iannaccone, P. M., & Walterhouse, D. O. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0441 · Cited by 54
WIP1 phosphatase modulates the Hedgehog signaling by enhancing GLI1 function
Pandolfi, S., Montagnani, V., Penachioni, J. Y., Vinci, M. C., Olivito, B., Borgognoni, L., & Stecca, B. A. (2012) · Oncogene · doi:10.1038/onc.2012.502 · Cited by 52
Self-citationJiang, Z., Cushing, L., Ai, X., & Lü, J. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0127oc · Cited by 50
Kebenko, M., Drenckhan, A., Gros, S. J., Jücker, M., Grabinski, N., Ewald, F., Grottke, A., Schultze, A., Izbicki, J. R., Bokemeyer, C., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.11.022 · Cited by 50
Han, Y., Xiong, Y., Shi, X., Wu, J. I., Zhao, Y., & Jiang, J. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2002063 · Cited by 50
Gruber, W., Peer, E., Elmer, D. P., Sternberg, C., Tesanovic, S., del Burgo, P. J., Coni, S., Canettieri, G., Neureiter, D., Bartz, R., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31117 · Cited by 50
Heterozygosity for Pten Promotes Tumorigenesis in a Mouse Model of Medulloblastoma
Castellino, R. C., Barwick, B. G., Schniederjan, M., Buss, M. C., Becher, O. J., Hambardzumyan, D., MacDonald, T. J., Brat, D. J., & Durden, D. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010849 · Cited by 49
Wang, W., Li, Q., Yang, Z., Duan, L., Yu, K., Zhang, L., Li, Y., Cai, X., Shen, T., & Xiong, W. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s71034 · Cited by 48
Magno, L. D., Basile, A., Coni, S., Manni, S., Sdruscia, G., D'Amico, D. F., Antonucci, L., Infante, P., Smaele, E. D., Cucchi, D., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7070 · Cited by 48
Pietrobono, S., Santini, R., Gagliardi, S., Dapporto, F., Colecchia, D., Chiariello, M., Leone, C., Valoti, M., Manetti, F., Petricci, E., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0142-0 · Cited by 48
Self-citationMenin Directly Represses Gli1 Expression Independent of Canonical Hedgehog Signaling
Gurung, B., Feng, Z., & Hua, X. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0170 · Cited by 47
Expression of theGLI2oncogene and its isoforms in human basal cell carcinoma
Tojo, M., Kiyosawa, H., Iwatsuki, K., et al. (2003) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2003.05284.x · Cited by 46
Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
Mizuarai, S., Kawagishi, A., & Kotani, H. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-44 · Cited by 46
Pietrobono, S., & Stecca, B. A. (2018) · Cells · doi:10.3390/cells7120272 · Cited by 46
Self-citationIwasaki, H., Nakano, K., Shinkai, K., Kunisawa, Y., Hirahashi, M., Oda, Y., Onishi, H., & Katano, M. (2012) · Cancer Science · doi:10.1111/cas.12073 · Cited by 40
Li, N., Truong, S., Nouri, M., Moore, J., Nakouzi, N. A., Lubik, A. A., & Buttyan, R. (2018) · Oncogene · doi:10.1038/s41388-017-0098-7 · Cited by 40
Asaoka, Y., Kanai, F., Ichimura, T., Tateishi, K., Tanaka, Y., Ohta, M., Seto, M., Tada, M., Ijichi, H., Ikenoue, T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.038232 · Cited by 38
Ehe, B. K., Lamson, D. R., Tarpley, M., Onyenwoke, R. U., Graves, L. M., & Williams, K. P. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.107 · Cited by 38
MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function
Lu, J., Liu, L., Zheng, M., Li, X., Wu, A., Wu, Q., Liao, C. L., Zou, J., & Song, H. (2018) · Oncogene · doi:10.1038/s41388-018-0249-5 · Cited by 38
Liu, Z., Li, T.-K., Reinhold, M. I., & Naski, M. C. (2012) · Oncogene · doi:10.1038/onc.2012.544 · Cited by 36
Identification of the gene transcription repressor domain of Gli3
Tsanev, R., Tiigimägi, P., Michelson, P., METSIS, M. L., Østerlund, T., & Kogerman, P. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.010 · Cited by 36
Zhao, J., Quan, H., Xie, C., & Lou, L. (2014) · Pharmacology Research & Perspectives · doi:10.1002/prp2.43 · Cited by 36
Yoon, J. W., Lamm, M. L. G., Iannaccone, S., Higashiyama, N., Leong, K.-F., Iannaccone, P. M., & Walterhouse, D. O. (2015) · DNA repair · doi:10.1016/j.dnarep.2015.06.006 · Cited by 35
Stathis, A., Hess, D., von Moos, R., Homicskó, K., Griguolo, G., Joerger, M., Mark, M. T., Ackermann, C. J., Allegrini, S., Catapano, C. V., et al. (2017) · Investigational New Drugs · doi:10.1007/s10637-017-0454-z · Cited by 32
Abe, Y., Suzuki, Y., Kawamura, K., & Tanaka, N. (2019) · Communications Biology · doi:10.1038/s42003-018-0275-4 · Cited by 32
Speek, M., Njunkova, O., Pata, I., Valdre, E., & Kogerman, P. (2006) · BMC Molecular Biology · doi:10.1186/1471-2199-7-13 · Cited by 31
GLI1 Blockade Potentiates the Antitumor Activity of PI3K Antagonists in Lung Squamous Cell Carcinoma
Kasiri, S., Shao, C., Chen, B., Wilson, A. N., Yenerall, P. M., Timmons, B. C., Girard, L., Tian, H., Behrens, C., Wistuba, I. I., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-3315 · Cited by 31
Antonucci, L., Di Magno, L., D'amico, D., Manni, S., Serrao, S., Di Pastena, F., Bordone, R., Yurtsever, Z., Caimano, M., Petroni, M., et al. (2018) · International Journal of Oncology · doi:10.3892/ijo.2018.4638 · Cited by 31
GLI2 induces genomic instability in human keratinocytes by inhibiting apoptosis
Pantazi, E., Gemenetzidis, E., Trigiante, G., Warnes, G., Shan, L., Mao, X., Ikram, M. S., Teh, M., Lu, Y., & Philpott, M. P. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.535 · Cited by 29
Cheng, Y., Lin, C., Chen, J.-Y., Li, C.-H., Liu, Y.-T., & Chen, B.-C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160593 · Cited by 29
Wen, J., Lee, J. J., Malhotra, A., Nahta, R., Arnold, A. R., Buss, M. C., Brown, B. D., Maier, C., Kenney, A. M., Remke, M., et al. (2016) · Oncogene · doi:10.1038/onc.2016.96 · Cited by 28
Zhang, R., Huang, S., Li, K. K., Li, Y.-H., Hsu, W.-H., Zhang, G., Chang, C.-J., & Yang, J.-Y. (2017) · Oncotarget · doi:10.18632/oncotarget.17769 · Cited by 25
WIP1 Enhances Tumor Formation in a Sonic Hedgehog–Dependent Model of Medulloblastoma
Doucette, T. A., Yang, Y., Pedone, C. A., Kim, J. Y. H., Dubuc, A. M., Northcott, P. A., Taylor, M. D., Fults, D. W., & Rao, G. (2011) · Neurosurgery · doi:10.1227/neu.0b013e31823e5332 · Cited by 24
Active IKKβ promotes the stability of GLI1 oncogene in diffuse large B-cell lymphoma
Agarwal, N. K., Kim, C. H., Kunkalla, K., Konno, H., Tjendra, Y., Kwon, D., Blonska, M., Kozloski, G. A., Moy, V. T., Verdun, R. E., et al. (2016) · Blood · doi:10.1182/blood-2015-07-658781 · Cited by 23
Sadam, H., Liivas, U., Kazantseva, A., Pruunsild, P., Kazantseva, J., Timmusk, T., Neuman, T., & Palm, K. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.10.008 · Cited by 18
Yang, Z., Ma, H., Sun, Z., Luo, L., Tian, S., Zheng, J., & Zhang, X. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.049 · Cited by 17
Role of GLI-1 in epidermal growth factor-induced invasiveness of ARCaPE prostate cancer cells
Zhu, G., Zhou, J., Song, W., Wu, D., Dang, Q., Zhang, L., LI, L., Wang, X., & He, D. (2013) · Oncology Reports · doi:10.3892/or.2013.2534 · Cited by 15
Trichostatin A promotes GLI1 degradation and P21 expression in multiple myeloma cells
Geng, Y., Liu, J., Xie, Y., Jiang, H., Zuo, K., Li, T., & Liu, Z. (2018) · Cancer Management and Research · doi:10.2147/cmar.s167330 · Cited by 15
Abballe, L., Mastronuzzi, A., Miele, E., Carai, A., Besharat, Z. M., Moretti, M., Smaele, E. D., Giangaspero, F., Locatelli, F., Ferretti, E., et al. (2018) · Frontiers in Pediatrics · doi:10.3389/fped.2018.00315 · Cited by 14
Chun, S. G., Park, H., PANDITA, R. K., Horikoshi, N., Pandita, T. K., Schwartz, D. L., & Yordy, J. S. (2015) · Europe PMC (PubMed Central) · Cited by 12
The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling
Diao, Y., Rahman, M. F., Villegas, V. E., Wickström, M., Johnsen, J. I., & Zaphiropoulos, P. G. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-600 · Cited by 9
Cited by
Signaling pathways and therapeutic interventions in gastric cancer
Lei, Z.-N., Teng, Q.-X., Tian, Q., Chen, W., Xie, Y., Wu, K., Zeng, Q., Zeng, L., Pan, Y., Chen, Z.-S., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01190-w · Cited by 322
The Hedgehog Signaling Pathway in Idiopathic Pulmonary Fibrosis: Resurrection Time
Effendi, W. I., & Nagano, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010171 · Cited by 59
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
Lospinoso Severini, L., Ghirga, F., Bufalieri, F., Quaglio, D., Infante, P., & Di Marcotullio, L. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1823967 · Cited by 61
Kaushal, J., Bhatia, R., Kanchan, R., Raut, P., Mallapragada, S., Ly, Q., Batra, S., & Rachagani, S. (2021) · Cancers · doi:10.3390/cancers13133105 · Cited by 35
Citarella, A., Catanzaro, G., Besharat, Z. M., Trocchianesi, S., Barbagallo, F., Gosti, G., Leonetti, M., Di Fiore, A., Coppola, L., Autilio, T. M., et al. (2023) · Cancers · doi:10.3390/cancers15051471 · Cited by 27
“Activated GLI translocate into the nucleus where they bind to DNA and activate the transcription of target genes [10].”
Background
Metadata
- Authors
- Pietrobono, S., Gagliardi, S., & Stecca, B.
- Venue
- Frontiers in Genetics
- Publisher
- Frontiers Media SA
- Published
- 2019-06-12
- Volume
- 10
- Pages
- 556-556
- ISSN
- 1664-8021 (ISSN-L)
- OpenAlex
- W2950970502
- Cited by
- 303
- References
- 191
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.